EUVIMEDEUVIMED entdecken
Crossref

Clinicopathological significance of unraveling mitochondrial pathway alterations in non‐small‐cell lung cancer

Kate L Hertweck, Kunwar S Vikramdeo, Jose N Galeas, Stephen M Marbut, Paramahansa Pramanik, Furhan Yunus, Seema Singh, Ajay P Singh, Santanu Dasgupta iD

The FASEB Journal · 2023

DOI: 10.1096/fj.202201724rr ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, 2023. Verfasst von Kate L Hertweck und 8 weiteren Autor:innen. Beteiligte Einrichtung: Ronin Institute, Montclair, New Jersey, USA. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Adenocarcinoma of Lung, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: University of South Alabama, Elsa U. Pardee Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Early detection, accurate monitoring, and therapeutics are major problems in non‐small‐cell lung cancer (NSCLC) patients. We identified genomic copy number variation of a unique panel of 40 mitochondria‐targeted genes in NSCLCs (GEOGSE #29365). Validation of mRNA expression of these molecules revealed an altered panel of 34 genes in lung adenocarcinomas (LUAD) and 36 genes in lung squamous cell carcinomas (LUSC). In the LUAD subtype ( n = 533), we identified 29 upregulated and 5 downregulated genes, while in the LUSC subtype ( n = 502), a panel of 30 upregulated and 6 downregulated genes were discovered. The majority of these genes are associated with mitochondrial protein transport, ferroptosis, calcium signaling, metabolism, OXPHOS function, TCA cycle, apoptosis, and MARylation. Altered mRNA expression of SLC25A4, ACSF2, MACROD1, and GCAT was associated with poor survival of the NSCLC patients. Progressive loss of SLC25A4 protein expression was confirmed in NSCLC tissues ( n = 59), predicting poor survival of the patients. Forced overexpression of SLC25A4 in two LUAD cell lines inhibited their growth, viability, and migration. A significant association of the altered mitochondrial pathway genes with LC subtype‐specific classical molecular signatures was observed, implicating the existence of nuclear‐mitochondrial cross‐talks. Key alteration signatures shared between LUAD and LUSC subtypes including SLC25A4 , ACSF2 , MACROD1 , MDH2 , LONP1 , MTHFD2 , and CA5A could be helpful in developing new biomarkers and therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsAdenocarcinoma of LungCarcinoma, Squamous CellHumansDNA Copy Number VariationsCalcium SignalingDNA, MitochondrialRNA, MessengerMitochondrial ProteinsATP-Dependent Proteases

Stichwörter der Autor:innen

OXPHOSTCA cycleapoptosisferroptosislung cancermitochondriaprotein transportribosome

Substanzen

DNA, MitochondrialRNA, MessengerLONP1 protein, humanMitochondrial ProteinsATP-Dependent Proteases

Autor:innen und Institutionen

  • Ronin Institute, Montclair, New Jersey, USA.
  • Department of Pathology, College of Medicine, University of South Alabama, Mobile, Alabama, USA.
  • Mitchell Cancer Institute, University of South Alabama, Mobile, Alabama, USA.
  • Mobile Infirmary Medical Center, Mobile, Alabama, USA.
  • Department of Mathematics and Statistics, University of South Alabama, Mobile, Alabama, USA.
  • Department of Biochemistry and Molecular Biology, University of South Alabama, Mobile, Alabama, USA.

ORCID-Profile: Santanu Dasgupta

Förderung

  • University of South Alabama
  • Elsa U. Pardee Foundation

Zitieren

APA

Hertweck, K. L., Vikramdeo, K. S., Galeas, J. N., Marbut, S. M., Pramanik, P., Yunus, F., Singh, S., Singh, A. P., & Dasgupta, S. (2023). Clinicopathological significance of unraveling mitochondrial pathway alterations in non‐small‐cell lung cancer. The FASEB Journal. https://doi.org/10.1096/fj.202201724rr

Vancouver

Hertweck KL, Vikramdeo KS, Galeas JN, Marbut SM, Pramanik P, Yunus F, et al. Clinicopathological significance of unraveling mitochondrial pathway alterations in non‐small‐cell lung cancer. The FASEB Journal. 2023. doi:10.1096/fj.202201724rr

BibTeX
@article{Hertweck2023,
  author = {Hertweck, Kate L and Vikramdeo, Kunwar S and Galeas, Jose N and Marbut, Stephen M and Pramanik, Paramahansa and Yunus, Furhan and Singh, Seema and Singh, Ajay P and Dasgupta, Santanu},
  title = {Clinicopathological significance of unraveling mitochondrial pathway alterations in non‐small‐cell lung cancer},
  journal = {The FASEB Journal},
  year = {2023},
  doi = {10.1096/fj.202201724rr}
}
Kostenlos starten →